The stock of KKR & Co. Inc (NYSE:KKR) last traded at $125.64, down -2.63% from the previous session.
KKR stock price is now 11.62% away from the 50-day moving average and -5.26% away from the 200-day moving average. The market capitalization of the company currently stands at $111.90B.
With the price target maintained at $150, Morgan Stanley recently Upgraded its rating from Equal-Weight to Overweight for KKR & Co. Inc (NYSE: KKR). On April 15, 2025, HSBC Securities Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $119, while ‘Wells Fargo’ rates the stock as ‘Overweight’
In other news, KKR Genetic Disorder L.P., 10% Owner sold 6,000,000 shares of the company’s stock on May 12 ’25. The stock was sold for $205,200,000 at an average price of $34.20. Upon completion of the transaction, the 10% Owner now directly owns 13,260,971 shares in the company, valued at $1.67 billion. An SEC document containing details of the transaction can be found on the SEC’s website. On May 06 ’25, Director SCULLY ROBERT W bought 13,250 shares of the business’s stock. A total of $1,503,733 was incurred on buying the stock at an average price of $113.49. This leaves the insider owning 13,250 shares of the company worth $1.66 million. A total of 23.84% of the company’s stock is owned by insiders.
During the past 12 months, KKR & Co. Inc has had a low of $86.15 and a high of $170.40.
The net profit margin was 13.32% and return on equity was 9.03% for KKR. The company reported revenue of $3.11 billion for the quarter, compared to $9.66 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -67.79 percent.
